Post-approval studies (Phase 4)Study completedNCT00681031
What this trial is testing
Zostavax® at Minimum Release Specification Approaching Expiry (V211-044)
Who this might be right for
Herpes Zoster
Merck Sharp & Dohme LLC 96
Showing 20 of 0 results